Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 1/20 | 0.39 |
| ▸ | CARM1 | Q86X55 | 5/20 | 0.38 |
| ▸ | PRMT6 | Q96LA8 | 5/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | KDM1A | O60341 | 2/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
| ▸ | HTR2B | P41595 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4118539 | 0.90 | CARM1 (0.39) | CXCR4CARM1PRMT6L3MBTL1KDM1A | |
| SCHEMBL4112325 | 0.87 | CARM1 (0.46) | CARM1PRMT6SIGMAR1 | |
| SCHEMBL4112400 | 0.87 | CARM1 (0.40) | CXCR4CARM1PRMT6L3MBTL1KDM1A | |
| SCHEMBL4112393 | 0.85 | CARM1 (0.44) | CARM1PRMT6L3MBTL1KDM1ASIGMAR1 | |
| SCHEMBL4130743 | 0.79 | MAOA (0.41) | KDM1ASIGMAR1 | |
| SCHEMBL4123524 | 0.78 | SIGMAR1 (0.55) | CARM1PRMT6SIGMAR1HTR2AHTR2C | |
| SCHEMBL2989331 | 0.77 | SIGMAR1 (0.41) | SIGMAR1 | |
| SCHEMBL4125387 | 0.77 | SIGMAR1 (0.41) | SIGMAR1 | |
| SCHEMBL4119403 | 0.77 | CARM1 (0.41) | CXCR4CARM1PRMT6L3MBTL1KDM1A | |
| SCHEMBL4282683 | 0.76 | MAOA (0.36) | L3MBTL1SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090253669-A1 | Substituted Sulfonamide Compounds | GRUENENTHAL GMBH (DE) | 2009-10-08 | — | — | US | disclosed |
| US-20090253669-A1 | Substituted Sulfonamide Compounds | GRUENENTHAL GMBH (DE) | 2009-10-08 | — | — | US | disclosed |
| US-20090253669-A1 | Substituted Sulfonamide Compounds | GRUENENTHAL GMBH (DE) | 2009-10-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090253669-A1 | Substituted Sulfonamide Compounds | SULT2A1, STS, SULT1A1 | CXCR4 3638/4885CARM1 4222/4885PRMT6 3888/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.